Aristotle University Of Thessaloniki (AUTH)
Κλινική μελέτη της απόπτωσης με βάση πρωτεΐνες του εγκεφαλονωτιαίου υγρού κα γνωσιακά προκλητά δυναμικά σε ασθενείς με ήπια νοητική έκπτωση
Abstract
dc:descriptionPatients with mild cognitive impairment (MCI) have memory problems bigger than those expected due to aging, but do not experience any impairment in any other cognitive functions such as thought, cognition and attention or difficulties in daily life activities. Apoptosis is a normal procedure, essential for the development of multicellular organisms, and is believed to play a role in MCI pathogenesis. The aim of this study was the examination of the cognitive function of MCI patients, the assessment of the apoptotic process, using measurements of cerebrospinal fluid proteins levels, and the finding of potential correlations between possible mechanisms involved in MCI and Alzheimer’s disease (AD). The study group consisted of a total of one hundred and twenty one (121) subjects of which ninety one (91) patients with MCI and thirty (30) healthy controls. The mean±SD age of the patient group was 67.1±6.9 years (range 46-83 years) and of the control subjects 68.7±9.9 years (range 49-90 years). The patient group consisted of 35 males and 56 females and the control group of 15 males and 15 females. The two groups were matched for age (t-test, t=-0.96, p=0.34) and gender (χ²=1.24, p=0.27). All subjects underwent: a) An examination with auditory event-related potentials (AERPs). The exam was performed in the Clinical Neurophysiology Department of the 3rd Neurological Clinic of the Aristotle University of Thessaloniki in the hospital “G. Papanikolaou”. From the 91 patients, who underwent an exam with AERPs, 43 were re-examined after an average period time of 12 months (range 7-17 months) and 11 after an average time of 22 months (18-26 months) from baseline. 22 patients underwent a third examination after an average time of 23 (±3) months from baseline. b) The MMSE neuropsychometric test. A clinical evaluation of the current disease situation was performed in MCI patients. Furthermore a lumbar puncture was performed in 54 patients and the levels of the CSF proteins: beta amyloid₁₋₄₂, tau, Bcl-2, Fas, Fas-L and cytochrome c were determined. In 20 of these patients a second sample of CSF was taken after an average period of 11.5 months. During the study period, five patients developed AD. A statistical analysis was performed in the results of all the parameters in control subjects and MCI patients. The results in the control subjects reveal a significant increase with age of the latencies of the AERP waves N200, P300 and SW. Furthermore the latencies of all waves correlate significantly with each other. Therefore it seems that each one is dependent upon the other. There is a highly significant association between P300-N200 latency difference and P300, whereas similar correlation exists between the difference between SW and P300 latencies and the difference between the latencies of SW and N200. The difference between SW and P300 latencies is highly correlated with SW wave latency and associated with P300 latency. From the statistical analysis of the results in the MCI patients, similar correlations as those of the control group were observed, except for the correlations between latency differences SW-N200 and SW-P300 and SW-P300 with latencies of P300 and SW, which do not exist in MCI patients. Moreover, no significant correlation was observed in MCI patients between their performance in MMSE and the characteristics of the three AERP waves. A significant increase was observed in N200 latency in the baseline examination of the MCI patients that later developed AD. The use of a cut-off value of 300 ms resulted in a high sensitivity and specificity in the discrimination between MCI and AD patients. Therefore, there are indications that N200 latency may serve as an accurate neurophysiological diagnostic marker for the early diagnosis of AD. Moreover a significant correlation was observed between beta-amyloid levels and N200 latency both in the baseline and follow up exam. The combination of these parameters (cut-off values >287 ms for N200 latency and <500 pg/ml for beta-amyloid) has the maximum diagnostic accuracy (100% sensitivity, 100% specificity) for the progression of MCI patients to AD. A great increase in the levels of CSF tau protein (4-fold) was observed, in the small number of MCI patients that developed AD. A similar increase was also noticed in the levels of Fas-L and cytochrome c in the same patients, a fact that supports the theory that apoptosis is involved in AD but not in MCI. On the other hand, in the MCI patients that did not develop AD, only the tau protein levels were increased. We believe that, these results, indicate that MCI and AD are two distinct and in many ways not relevant clinical entities. It may be that MCI serves as an aggravating factor for the development of AD but it is not a causal factor for AD. Furthermore, in our view, the correlations that exist between CSF cytochrome c levels and N200 amplitude, as well as between CSF beta-amyloid levels and N200 latency (which implies that N200 amplitudes are influenced by whatever processes accompany changes in beta-amyloid during MCI), indicates that MCI probably attacks those cells of the human cortex that are involved in lateral inhibition.
Degree
thesis:*- Grantor dc:publisher
- Aristotle University Of Thessaloniki (AUTH)
- Year dc:date
- 2008
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Papaliagkas, Vasileios
- Παπαλιάγκας, Βασίλειος
Subjects
dc:subject × 20- Νοητική διαταραχή, Ήπια
- Απόπτωση
- Γνωσιακά προκλητά δυναμικά
- Έπαρμα Ν200
- Έπαρμα P300
- Πρωτεΐνες εγκεφαλονωτιαίου υγρού (ΕΝΥ)
- Νόσος Αλτσχάιμερ (ΝΑ)
- Κυτόχρωμα C
- Mild cognitive impairment (MCI)
- Apoptosis
- Event related potentials (ERP)
- N200 wave
- P300 wave
- Cerebrospinal fluid proteins (CSF)
- Alzheimer's disease
- Cytochrome C
- Ιατρική και Επιστήμες Υγείας
- Κλινική Ιατρική
- Medical and Health Sciences
- Clinical Medicine
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/25452